FDA NDC Directory · JSON-LD · Markdown

Clobazam

NDC 31722-641 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerCamber Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA209796
Dosage form / routeSUSPENSION · ORAL
Active ingredientsCLOBAZAM (2.5 mg/mL)
Marketing started20200224
Package count1

External sources

Source: openFDA. Public-domain (CC0).